Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.
暂无分享,去创建一个
W. Mitzner | D. Fairweather | K. Gabrielson | Michael J. Coronado | D. Bedja | Jessica E. Brandt | Eunyong Kim | Adriana Bucek | E. Abston | J. Shin | Michael Coronado
[1] Sandeep Sagar,et al. Myocarditis , 2012, The Lancet.
[2] David A. Bluemke,et al. Cardiac remodeling at the population level—risk factors, screening, and outcomes , 2011, Nature Reviews Cardiology.
[3] L. Cooper,et al. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. , 2011, Journal of the American College of Cardiology.
[4] S. Werner,et al. Pivotal Role for α1-Antichymotrypsin in Skin Repair* , 2011, The Journal of Biological Chemistry.
[5] T. Guilarte,et al. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice , 2011, Biology of Sex Differences.
[6] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[7] M. Martinka,et al. Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma , 2010, Pigment cell & melanoma research.
[8] Roland Hetzer,et al. Sex and gender differences in myocardial hypertrophy and heart failure. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[9] U. Eriksson,et al. Mechanisms of cardiac fibrosis in inflammatory heart disease. , 2009, Trends in cardiovascular medicine.
[10] Q. Tang,et al. The effects of NK4 on viral myocarditis mice. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[11] M. Friedrich,et al. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study , 2009, Heart.
[12] M. Asakura,et al. Global gene expression profiling in the failing myocardium. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[13] S. Klein,et al. Gonadectomy of male BALB/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis , 2009, Brain, Behavior, and Immunity.
[14] T. Elton,et al. Cardiomyopathy: an overview. , 2009, American family physician.
[15] M. Kimura,et al. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. , 2008, The American journal of pathology.
[16] S. Crosby,et al. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. , 2008, Physiological genomics.
[17] B. McManus,et al. Ablation of Matrix Metalloproteinase-9 Increases Severity of Viral Myocarditis in Mice , 2008, Circulation.
[18] A. Angelini,et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.
[19] N. Rose,et al. Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease1 , 2007, The Journal of Immunology.
[20] E. Murphy,et al. Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. , 2007, Journal of molecular and cellular cardiology.
[21] Q. Tang,et al. Microarray analysis reveals the role of matrix metalloproteinases in mouse experimental autoimmune myocarditis induced by cardiac myosin peptides , 2007, Cellular & Molecular Biology Letters.
[22] Ulrich Mansmann,et al. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. , 2006, Journal of the American College of Cardiology.
[23] G. Korbutt,et al. Identification of a Novel Human Granzyme B Inhibitor Secreted by Cultured Sertoli Cells1 , 2006, The Journal of Immunology.
[24] M. Cavasin,et al. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. , 2006, American journal of physiology. Heart and circulatory physiology.
[25] Peter P. Liu,et al. Matrix metalloproteinases in cardiovascular disease. , 2006, The Canadian journal of cardiology.
[26] J. Whisstock,et al. The Murine Orthologue of Human Antichymotrypsin , 2005, Journal of Biological Chemistry.
[27] S. Akira,et al. Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production , 2005, Circulation.
[28] P. Carmeliet,et al. Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart , 2005, Circulation.
[29] B. Teter,et al. Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models , 2005, Neuropsychopharmacology.
[30] P. Coughlin,et al. Expression Patterns of Murine Antichymotrypsin-like Genes Reflect Evolutionary Divergence at the Serpina3 Locus , 2004, Journal of Molecular Evolution.
[31] Raimond L Winslow,et al. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.
[32] N. Rose,et al. IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication1 , 2003, The Journal of Immunology.
[33] G. Glass,et al. Sex Differences in Seoul Virus Infection Are Not Related to Adult Sex Steroid Concentrations in Norway Rats , 2000, Journal of Virology.
[34] B. McManus,et al. Host Gene Regulation During Coxsackievirus B3 Infection in Mice: Assessment by Microarrays , 2000, Circulation research.
[35] D. Pipeleers,et al. IL-1beta induces serine protease inhibitor 3 (SPI-3) gene expression in rat pancreatic beta-cells. Detection by differential display of messenger RNA. , 1999, Cytokine.
[36] M. Krieg,et al. Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens. , 1979, Endocrinology.
[37] R. Hruban,et al. Transcriptomic biomarkers for the accurate diagnosis of myocarditis. , 2011, Circulation.
[38] Y. Asmann,et al. Genomic and proteomic analysis of myocarditis and dilated cardiomyopathy. , 2010, Heart failure clinics.
[39] M. Cheitlin. Amelioration of Coxsackievirus B3-Mediated Myocarditis by Inhibition of Tissue Inhibitors of Matrix Metalloproteinase-1 , 2009 .
[40] N. Rose,et al. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. , 2007, Methods.
[41] R. Schnabel,et al. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study. , 2006, European heart journal.
[42] P. Brauer. MMPs--role in cardiovascular development and disease. , 2006, Frontiers in bioscience : a journal and virtual library.
[43] N. Rose,et al. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus‐induced myocarditis , 2005, Reviews in medical virology.
[44] B. Teter,et al. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models. , 2005, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[45] N. Rose,et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.
[46] N. Rose,et al. Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .